Oluwatoyin A. Adeleke

Education

• BPharm (University of Ibadan, NG)
• MPharm with Distinction (Pharmaceutical Sciences) (University of the Witwatersrand, RSA)
• PhD (Pharmaceutics) (University of the Witwatersrand, RSA)
• DST/NRF Innovation Postdoctoral Fellowship (Council for Scientific and Industrial Research, RSA)
• Postdoctoral Researcher (Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, USA)

Research interests

Research and training activities at the Preclinical Laboratory for Drug Delivery Innovations (PLaDDI) focus on the design of novel drug delivery technologies (i.e., nano/micro/macro formulations) for the effective management of different human ailments, employing cutting-edge in vitro, ex vivo, in vivo  and in silico evaluation strategies with the core objectives of enhancing pharmacotherapeutic efficacy, improving scale-up processes and production cost, thereby optimizing patient care, affordability and compliance. 

Selected awards and honours

• University of Witwatersrand Wall of Fame, 2022
• L’Oréal-UNESCO for Women in Science Sub-Saharan Africa Regional Fellowship, 2014/2015
• Fullbright Scholar Award 2014

Selected publication

• Oluwatoyin A. Adeleke and Saba Abedin*. Characterization of prototype gummy formulations provides insight into setting quality standards. AAPS PharmSciTech, 25(6), p.155, 2024. https://link.springer.com/article/10/1208/s12249-024-02876-w.
• Emma A. Kean*, Oluwatoyin A. Adeleke. A child-friendly anti-infective gummy formulation: design, physicochemical, micromechanical, and taste sensory evaluation. Drug Delivery and Translational Research, 2024, 14:1319-1337. Available at: https//doi.org/10.1007/s13346-023-01464-y.
• Anna Yusuf Aliyu*, Oluwatoyin A. Adeleke. Nanofibrous scaffolds for diabetic would healing. Pharmaceutics, 2023, 15(3):986. Available at https://doi.org/10.3390/pharmaceutics15030986.
• Penelope N. Rampedi*, Modupe O. Ogunrombi, James Wesley-Smith, and Oluwatoyin A. Adeleke. A micro-configured multiparticulate reconstitutable suspension powder of fixed dose rifampicin and pyrazinamide: optimal fabrication and in vitro quality evaluation. Pharmaceutics, 2023, 15(1): 64. Available at https://doi.org/10.3390/pharmaceutics15010064.
• Oluwatoyin A. Adeleke, Logan Fisher, Ian N. Moore, Glenn A. Nardone, and Alan Sher. A Long-Acting Thermoresponsive Injectable Formulation of Tin Protoporphyrin Sustains Antitubercular Efficacy in a Murine Infection Model. ACS Pharmacology & Translational Science, 4 (1): 276-287, 2021. DOI: 10.1021/acsptsci.0c00185.

   *Names of research trainees